BofA lowered the firm’s price target on Nuveen Churchill (NCDL) to $14 from $15.25 and keeps a Buy rating on the shares. The firm is adjusting estimates and targets for multiple business development companies following their Q1 prints.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NCDL:
- Nuveen Churchill price target lowered to $14.75 from $15.50 at UBS
- Nuveen Churchill reports Q1 NII 41c, consensus 42c
- Nuveen Churchill declares Q2 distribution of 38c per share
- Nuveen Churchill Reports Q1 2026 Results, Declares Dividend
- Nuveen Churchill price target raised to $15.50 from $14.75 at UBS